{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:04Z","timestamp":1787020084955,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Innovation Application Research Project of Soochow Science and Technology Bureau","award":["SKY2023086"],"award-info":[{"award-number":["SKY2023086"]}]},{"name":"\u201cNational Mentoring System\u201d Training Program for Young Talents in the Soochow Healthcare Field","award":["Qngg2023036"],"award-info":[{"award-number":["Qngg2023036"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270187"],"award-info":[{"award-number":["32270187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04637-6","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T03:45:47Z","timestamp":1766202347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genomic analysis of a clinical Mycolicibacterium houstonense isolate reveals dual escalation in adaptability and virulence"],"prefix":"10.1186","volume":"26","author":[{"given":"Ailing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nifang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"4637_CR1","doi-asserted-by":"crossref","unstructured":"Pavlik I, Ulmann V, Hubelova D, Weston RT. Nontuberculous mycobacteria as sapronoses: A review. Microorganisms. 2022;10(7).","DOI":"10.3390\/microorganisms10071345"},{"key":"4637_CR2","doi-asserted-by":"crossref","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr., Andrejak C, Bottger EC, Brozek J, Griffith DE, Guglielmetti L et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535.","DOI":"10.1183\/13993003.00535-2020"},{"key":"4637_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.rmed.2019.05.001","volume":"152","author":"K Furuuchi","year":"2019","unstructured":"Furuuchi K, Morimoto K, Yoshiyama T, Tanaka Y, Fujiwara K, Okumura M, Izumi K, Shiraishi Y, Mitarai S, Ogata H, et al. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Respir Med. 2019;152:74\u201380.","journal-title":"Respir Med"},{"issue":"1","key":"4637_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","volume":"36","author":"DR Prevots","year":"2015","unstructured":"Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13\u201334.","journal-title":"Clin Chest Med"},{"issue":"6","key":"4637_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jinf.2016.03.008","volume":"72","author":"GS Smith","year":"2016","unstructured":"Smith GS, Ghio AJ, Stout JE, Messier KP, Hudgens EE, Murphy MS, Pfaller SL, Maillard JM, Hilborn ED. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006\u20132010. J Infect. 2016;72(6):678\u201386.","journal-title":"J Infect"},{"issue":"12","key":"4637_CR6","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1086\/504381","volume":"42","author":"MA De Groote","year":"2006","unstructured":"De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2006;42(12):1756\u201363.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"4","key":"4637_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4637_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2217\/fmb.13.138","volume":"9","author":"CC Lai","year":"2014","unstructured":"Lai CC, Hsueh PR. Diseases caused by nontuberculous mycobacteria in Asia. Future Microbiol. 2014;9(1):93\u2013106.","journal-title":"Future Microbiol"},{"issue":"Pt 5","key":"4637_CR9","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1099\/ijs.0.02743-0","volume":"54","author":"MF Schinsky","year":"2004","unstructured":"Schinsky MF, Morey RE, Steigerwalt AG, Douglas MP, Wilson RW, Floyd MM, Butler WR, Daneshvar MI, Brown-Elliott BA, Wallace RJ, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium Houstonense sp. nov., Mycobacterium neworleansense sp. nov. And Mycobacterium Brisbanense sp. nov. And recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol. 2004;54(Pt 5):1653\u201367.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"10","key":"4637_CR10","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1128\/AAC.00402-06","volume":"50","author":"KA Nash","year":"2006","unstructured":"Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother. 2006;50(10):3476\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4637_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/1751-7915.14146","volume":"16","author":"D Rodriguez-Temporal","year":"2023","unstructured":"Rodriguez-Temporal D, Zvezdanova ME, Benedi P, Marin M, Blazquez-Sanchez M, Ruiz-Serrano MJ, Munoz P, Rodriguez-Sanchez B. Identification of nocardia and non-tuberculous Mycobacterium species by MALDI-TOF MS using the VITEK MS coupled to IVD and RUO databases. Microb Biotechnol. 2023;16(4):778\u201383.","journal-title":"Microb Biotechnol"},{"issue":"14","key":"4637_CR12","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"4637_CR13","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1038\/s41467-018-07641-9","volume":"9","author":"C Jain","year":"2018","unstructured":"Jain C, Rodriguez RL, Phillippy AM, Konstantinidis KT, Aluru S. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat Commun. 2018;9(1):5114.","journal-title":"Nat Commun"},{"issue":"3","key":"4637_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/molbev\/msz284","volume":"37","author":"F Sitto","year":"2019","unstructured":"Sitto F, Battistuzzi FU. Estimating pangenomes with Roary. Mol Biol Evol. 2019;37(3):933\u20139.","journal-title":"Mol Biol Evol"},{"issue":"15","key":"4637_CR15","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","volume":"27","author":"P Danecek","year":"2011","unstructured":"Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, Handsaker RE, Lunter G, Marth GT, Sherry ST, et al. The variant call format and vcftools. Bioinformatics. 2011;27(15):2156\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"4637_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/molbev\/msu300","volume":"32","author":"LT Nguyen","year":"2015","unstructured":"Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32(1):268\u201374.","journal-title":"Mol Biol Evol"},{"issue":"6","key":"4637_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nmeth.4285","volume":"14","author":"S Kalyaanamoorthy","year":"2017","unstructured":"Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14(6):587\u20139.","journal-title":"Nat Methods"},{"issue":"W1","key":"4637_CR18","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic I, Bork P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4637_CR19","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/gb-2008-9-10-r151","volume":"9","author":"M Wu","year":"2008","unstructured":"Wu M, Eisen JA. A simple, fast, and accurate method of phylogenomic inference. Genome Biol. 2008;9(10):R151.","journal-title":"Genome Biol"},{"issue":"5","key":"4637_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1472-765X.2011.03045.x","volume":"52","author":"GJ Ngan","year":"2011","unstructured":"Ngan GJ, Ng LM, Jureen R, Lin RT, Teo JW. Development of multiplex PCR assays based on the 16S-23S rRNA internal transcribed spacer for the detection of clinically relevant nontuberculous mycobacteria. Lett Appl Microbiol. 2011;52(5):546\u201354.","journal-title":"Lett Appl Microbiol"},{"issue":"D1","key":"4637_CR21","doi-asserted-by":"publisher","first-page":"D912","DOI":"10.1093\/nar\/gkab1107","volume":"50","author":"B Liu","year":"2022","unstructured":"Liu B, Zheng D, Zhou S, Chen L, Yang J. VFDB 2022: a general classification scheme for bacterial virulence factors. Nucleic Acids Res. 2022;50(D1):D912\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4637_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrmicro.2016.131","volume":"14","author":"MI Groschel","year":"2016","unstructured":"Groschel MI, Sayes F, Simeone R, Majlessi L, Brosch R. ESX secretion systems: mycobacterial evolution to counter host immunity. Nat Rev Microbiol. 2016;14(11):677\u201391.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"4637_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1556\/1886.2020.00028","volume":"10","author":"S Roy","year":"2020","unstructured":"Roy S, Ghatak D, Das P, BoseDasgupta S. ESX secretion system: the gatekeepers of mycobacterial survivability and pathogenesis. Eur J Microbiol Immunol. 2020;10(4):202\u20139.","journal-title":"Eur J Microbiol Immunol"},{"key":"4637_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tube.2018.09.001","volume":"113","author":"A Kashyap","year":"2018","unstructured":"Kashyap A, Singh PK, Silakari O. Chemical classes targeting energy supplying GyrB domain of Mycobacterium tuberculosis. Tuberc (Edinb Scotl). 2018;113:43\u201354.","journal-title":"Tuberc (Edinb Scotl)"},{"key":"4637_CR25","doi-asserted-by":"publisher","first-page":"105849","DOI":"10.1016\/j.meegid.2025.105849","volume":"136","author":"S Kim","year":"2025","unstructured":"Kim S, Kim HJ, Heo R, Kim HS, Song JM, Kim CT, Kim HJ, Kim SH, Gwon JH, Bae G, et al. Mutations in GyrA and GyrB among drug-resistant Mycobacterium tuberculosis isolates in South Korea. Infect Genet Evolution: J Mol Epidemiol Evolutionary Genet Infect Dis. 2025;136:105849.","journal-title":"Infect Genet Evolution: J Mol Epidemiol Evolutionary Genet Infect Dis"},{"issue":"10","key":"4637_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4155\/fmc-2017-0257","volume":"10","author":"M Baran\u010dokov\u00e1","year":"2018","unstructured":"Baran\u010dokov\u00e1 M, Kikelj D, Ila\u0161 J. Recent progress in the discovery and development of DNA gyrase B inhibitors. Future Med Chem. 2018;10(10):1207\u201327.","journal-title":"Future Med Chem"},{"key":"4637_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jgar.2017.01.005","volume":"9","author":"AD Khosravi","year":"2017","unstructured":"Khosravi AD, Etemad N, Hashemzadeh M, Khandan Dezfuli S, Goodarzi H. Frequency of Rrs and RpsL mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from Iranian patients. J Global Antimicrob Resist. 2017;9:51\u20136.","journal-title":"J Global Antimicrob Resist"},{"key":"4637_CR28","doi-asserted-by":"crossref","unstructured":"Dal Molin M, Gut M, Rominski A, Haldimann K, Becker K, Sander P. Molecular mechanisms of intrinsic streptomycin resistance in Mycobacterium abscessus. Antimicrob Agents Chemother. 2018;62(1):e01427\u201317.","DOI":"10.1128\/AAC.01427-17"},{"issue":"49","key":"4637_CR29","doi-asserted-by":"publisher","first-page":"45876","DOI":"10.1074\/jbc.M108810200","volume":"276","author":"SS Hegde","year":"2001","unstructured":"Hegde SS, Javid-Majd F, Blanchard JS. Overexpression and mechanistic analysis of chromosomally encoded aminoglycoside 2\u2019-N-acetyltransferase (AAC(2\u2019)-Ic) from Mycobacterium tuberculosis. J Biol Chem. 2001;276(49):45876\u201381.","journal-title":"J Biol Chem"},{"issue":"11","key":"4637_CR30","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1128\/AAC.00223-06","volume":"50","author":"S Ram\u00f3n-Garc\u00eda","year":"2006","unstructured":"Ram\u00f3n-Garc\u00eda S, Otal I, Mart\u00edn C, G\u00f3mez-Lus R, A\u00ednsa JA. Novel streptomycin resistance gene from Mycobacterium fortuitum. Antimicrob Agents Chemother. 2006;50(11):3920\u20132.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4637_CR31","doi-asserted-by":"publisher","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","volume":"7","author":"SB Georghiou","year":"2012","unstructured":"Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, Kanamycin and capreomycin: a systematic review. PLoS ONE. 2012;7(3):e33275.","journal-title":"PLoS ONE"},{"issue":"11","key":"4637_CR32","doi-asserted-by":"publisher","first-page":"e0239354","DOI":"10.1371\/journal.pone.0239354","volume":"15","author":"L Flint","year":"2020","unstructured":"Flint L, Korkegian A, Parish T. InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis. PLoS ONE. 2020;15(11):e0239354.","journal-title":"PLoS ONE"},{"issue":"10","key":"4637_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cmi.2020.07.004","volume":"26","author":"E Rivi\u00e8re","year":"2020","unstructured":"Rivi\u00e8re E, Whitfield MG, Nelen J, Heupink TH, Van Rie A. Identifying Isoniazid resistance markers to guide inclusion of high-dose Isoniazid in tuberculosis treatment regimens. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2020;26(10):1332\u20137.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"key":"4637_CR34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of Isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evolution: J Mol Epidemiol Evolutionary Genet Infect Dis. 2016;45:474\u201392.","journal-title":"Infect Genet Evolution: J Mol Epidemiol Evolutionary Genet Infect Dis"},{"issue":"2","key":"4637_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2958.2002.03162.x","volume":"46","author":"MH Larsen","year":"2002","unstructured":"Larsen MH, Vilch\u00e8ze C, Kremer L, Besra GS, Parsons L, Salfinger M, Heifets L, Hazbon MH, Alland D, Sacchettini JC, et al. Overexpression of inhA, but not kasA, confers resistance to Isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Mol Microbiol. 2002;46(2):453\u201366.","journal-title":"Mol Microbiol"},{"key":"4637_CR36","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.watres.2019.06.048","volume":"161","author":"S Zhou","year":"2019","unstructured":"Zhou S, Zhu Y, Yan Y, Wang W, Wang Y. Deciphering extracellular antibiotic resistance genes (eARGs) in activated sludge by metagenome. Water Res. 2019;161:610\u201320.","journal-title":"Water Res"},{"issue":"1","key":"4637_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/mmi.13750","volume":"106","author":"SM Prezioso","year":"2017","unstructured":"Prezioso SM, Brown NE, Goldberg JB. Elfamycins: inhibitors of elongation factor-Tu. Mol Microbiol. 2017;106(1):22\u201334.","journal-title":"Mol Microbiol"},{"issue":"12","key":"4637_CR38","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1128\/AAC.00656-06","volume":"50","author":"S Buroni","year":"2006","unstructured":"Buroni S, Manina G, Guglierame P, Pasca MR, Riccardi G, De Rossi E. LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. Antimicrob Agents Chemother. 2006;50(12):4044\u201352.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4637_CR39","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1128\/AAC.01367-15","volume":"60","author":"GB Novotna","year":"2015","unstructured":"Novotna GB, Kwun MJ, Hong HJ. In vivo characterization of the activation and interaction of the VanR-VanS two-Component regulatory system controlling glycopeptide antibiotic resistance in two related streptomyces species. Antimicrob Agents Chemother. 2015;60(3):1627\u201337.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4637_CR40","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1128\/AAC.49.2.708-720.2005","volume":"49","author":"C Vilch\u00e8ze","year":"2005","unstructured":"Vilch\u00e8ze C, Weisbrod TR, Chen B, Kremer L, Hazb\u00f3n MH, Wang F, Alland D, Sacchettini JC, Jacobs WR Jr. Altered NADH\/NAD\u2009+\u2009ratio mediates coresistance to Isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother. 2005;49(2):708\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4637_CR41","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1365-2958.2008.06365.x","volume":"69","author":"C Vilch\u00e8ze","year":"2008","unstructured":"Vilch\u00e8ze C, Av-Gay Y, Attarian R, Liu Z, Hazb\u00f3n MH, Colangeli R, Chen B, Liu W, Alland D, Sacchettini JC, et al. Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis. Mol Microbiol. 2008;69(5):1316\u201329.","journal-title":"Mol Microbiol"},{"issue":"8","key":"4637_CR42","doi-asserted-by":"publisher","first-page":"e0026124","DOI":"10.1128\/aac.00261-24","volume":"68","author":"AH Roberts","year":"2024","unstructured":"Roberts AH, Moon CW, Faulkner V, Kendall SL, Waddell SJ, Bacon J. EfpA is required for regrowth of Mycobacterium tuberculosis following Isoniazid exposure. Antimicrob Agents Chemother. 2024;68(8):e0026124.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4637_CR43","first-page":"468","volume":"45","author":"TL Teng","year":"2022","unstructured":"Teng TL, Shang YY, Huang HR, Chu NH, Chen ST. [Effects of four efflux pump inhibitors on the activities of clarithromycin against Mycobacterium abscessus]. Zhonghua Jie He He Hu Xi Za zhi = Zhonghua Jiehe He Huxi Zazhi = Chin J Tuberculosis Respiratory Dis. 2022;45(5):468\u201374.","journal-title":"Zhonghua Jie He He Hu Xi Za zhi = Zhonghua Jiehe He Huxi Zazhi = Chin J Tuberculosis Respiratory Dis"},{"issue":"4","key":"4637_CR44","first-page":"290","volume":"31","author":"F Li","year":"2018","unstructured":"Li F, Li GL, Pang H, Liu HC, Xiao TY, Li SJ, Luo Q, Jiang Y, Wang RB, Wan KL. Preliminary study on drug susceptibility profile and resistance mechanisms to macrolides of clinical isolates of Non-tuberculous mycobacteria from China. Biomed Environ Sci: BES. 2018;31(4):290\u20139.","journal-title":"Biomed Environ Sci: BES"},{"issue":"3","key":"4637_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2958.1994.tb01037.x","volume":"12","author":"J Timm","year":"1994","unstructured":"Timm J, Perilli MG, Duez C, Trias J, Orefici G, Fattorini L, Amicosante G, Oratore A, Joris B, Fr\u00e8re JM, et al. Transcription and expression analysis, using LacZ and PhoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer. Mol Microbiol. 1994;12(3):491\u2013504.","journal-title":"Mol Microbiol"},{"issue":"5","key":"4637_CR46","doi-asserted-by":"publisher","first-page":"e0094623","DOI":"10.1128\/mbio.00946-23","volume":"14","author":"S Bobba","year":"2023","unstructured":"Bobba S, Howard NC, Das S, Ahmed M, Tang L, Thirunavukkarasu S, Larsen MH, Mathema B, Divangahi M, Khader SA. Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring RpoB mutation H445Y is associated with suppressed immunity through type I interferons. mBio. 2023;14(5):e0094623.","journal-title":"mBio"},{"issue":"Pt 11","key":"4637_CR47","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1099\/00221287-145-11-3177","volume":"145","author":"KAL De Smet","year":"1999","unstructured":"De Smet KAL, Kempsell KE, Gallagher A, Duncan K, Young DB. Alteration of a single amino acid residue reverses fosfomycin resistance of Recombinant MurA from Mycobacterium tuberculosis. Microbiology. 1999;145(Pt 11):3177\u201384.","journal-title":"Microbiology"},{"issue":"6","key":"4637_CR48","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1365-2958.2005.04510.x","volume":"55","author":"R Colangeli","year":"2005","unstructured":"Colangeli R, Helb D, Sridharan S, Sun J, Varma-Basil M, Hazb\u00f3n MH, Harbacheuski R, Megjugorac NJ, Jacobs WR Jr., Holzenburg A, et al. The Mycobacterium tuberculosis IniA gene is essential for activity of an efflux pump that confers drug tolerance to both Isoniazid and ethambutol. Mol Microbiol. 2005;55(6):1829\u201340.","journal-title":"Mol Microbiol"},{"issue":"3","key":"4637_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mlf2.12139","volume":"3","author":"J He","year":"2024","unstructured":"He J, Gao Y, Wang J, Hameed HMA, Wang S, Fang C, Tian X, Zhang J, Han X, Ju Y, et al. EmbB and EmbC regulate the sensitivity of Mycobacterium abscessus to echinomycin. mLife. 2024;3(3):459\u201370.","journal-title":"mLife"},{"issue":"1","key":"4637_CR50","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1038\/s41598-020-65173-z","volume":"10","author":"K Vallejos-S\u00e1nchez","year":"2020","unstructured":"Vallejos-S\u00e1nchez K, Lopez JM, Antiparra R, Toscano E, Saavedra H, Kirwan DE, Amzel LM, Gilman RH, Maruenda H, Sheen P, et al. Mycobacterium tuberculosis ribosomal protein S1 (RpsA) and variants with truncated C-terminal end show absence of interaction with Pyrazinoic acid. Sci Rep. 2020;10(1):8356.","journal-title":"Sci Rep"},{"key":"4637_CR51","doi-asserted-by":"crossref","unstructured":"Shi W, Cui P, Niu H, Zhang S, T\u00f8njum T, Zhu B, Zhang Y. Introducing RpsA point mutations \u2206438A and D123A into the chromosome of Mycobacterium tuberculosis confirms their role in causing resistance to Pyrazinamide. Antimicrob Agents Chemother. 2019;63(6):e02681\u201318.","DOI":"10.1128\/AAC.02681-18"},{"issue":"14","key":"4637_CR52","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1093\/nar\/gks346","volume":"40","author":"Y Hu","year":"2012","unstructured":"Hu Y, Morichaud Z, Chen S, Leonetti JP, Brodolin K. Mycobacterium tuberculosis RbpA protein is a new type of transcriptional activator that stabilizes the \u03c3 A-containing RNA polymerase holoenzyme. Nucleic Acids Res. 2012;40(14):6547\u201357.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4637_CR53","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1128\/AAC.41.11.2456","volume":"41","author":"S Quan","year":"1997","unstructured":"Quan S, Venter H, Dabbs ER. Ribosylative inactivation of Rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic. Antimicrob Agents Chemother. 1997;41(11):2456\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4637_CR54","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.chembiol.2018.01.009","volume":"25","author":"K Koteva","year":"2018","unstructured":"Koteva K, Cox G, Kelso JK, Surette MD, Zubyk HL, Ejim L, Stogios P, Savchenko A, S\u00f8rensen D, Wright GD. Rox, a rifamycin resistance enzyme with an unprecedented mechanism of action. Cell Chem Biology. 2018;25(4):403\u2013e412405.","journal-title":"Cell Chem Biology"},{"issue":"1","key":"4637_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12941-022-00537-z","volume":"21","author":"W Wang","year":"2022","unstructured":"Wang W, Li S, Ge Q, Guo H, Shang Y, Ren W, Wang Y, Xue Z, Lu J, Pang Y. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, FolC and DfrA mutations. Ann Clin Microbiol Antimicrob. 2022;21(1):48.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4637_CR56","doi-asserted-by":"publisher","first-page":"367021","DOI":"10.1155\/2013\/367021","volume":"2013","author":"W Buwembo","year":"2013","unstructured":"Buwembo W, Aery S, Rwenyonyi CM, Swedberg G, Kironde F. Point mutations in the folp gene partly explain sulfonamide resistance of Streptococcus mutans. Int J Microbiol. 2013;2013:367021.","journal-title":"Int J Microbiol"},{"issue":"2","key":"4637_CR57","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jac\/dki436","volume":"57","author":"S Ram\u00f3n-Garc\u00eda","year":"2006","unstructured":"Ram\u00f3n-Garc\u00eda S, Mart\u00edn C, A\u00ednsa JA, De Rossi E. Characterization of Tetracycline resistance mediated by the efflux pump tap from Mycobacterium fortuitum. J Antimicrob Chemother. 2006;57(2):252\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4637_CR58","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1128\/AAC.42.8.1931","volume":"42","author":"E De Rossi","year":"1998","unstructured":"De Rossi E, Blokpoel MC, Cantoni R, Branzoni M, Riccardi G, Young DB, De Smet KA, Ciferri O. Molecular cloning and functional analysis of a novel Tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob Agents Chemother. 1998;42(8):1931\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4637_CR59","doi-asserted-by":"publisher","first-page":"dlab028","DOI":"10.1093\/jacamr\/dlab028","volume":"3","author":"A Maitra","year":"2021","unstructured":"Maitra A, Nukala S, Dickman R, Martin LT, Munshi T, Gupta A, Shepherd AJ, Arnvig KB, Tabor AB, Keep NH, et al. Characterization of the MurT\/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target. JAC-antimicrobial Resist. 2021;3(1):dlab028.","journal-title":"JAC-antimicrobial Resist"},{"issue":"4","key":"4637_CR60","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1365-2958.2005.04899.x","volume":"58","author":"G Harth","year":"2005","unstructured":"Harth G, Maslesa-Galic S, Tullius MV, Horwitz MA. All four Mycobacterium tuberculosis GlnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis. Mol Microbiol. 2005;58(4):1157\u201372.","journal-title":"Mol Microbiol"},{"issue":"39","key":"4637_CR61","doi-asserted-by":"publisher","first-page":"19665","DOI":"10.1073\/pnas.1907631116","volume":"116","author":"H Safi","year":"2019","unstructured":"Safi H, Gopal P, Lingaraju S, Ma S, Levine C, Dartois V, Yee M, Li L, Blanc L, Ho Liang HP, et al. Phase variation in Mycobacterium tuberculosis GlpK produces transiently heritable drug tolerance. Proc Natl Acad Sci USA. 2019;116(39):19665\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"4637_CR62","doi-asserted-by":"publisher","first-page":"e0040021","DOI":"10.1128\/IAI.00400-21","volume":"89","author":"O Gazioglu","year":"2021","unstructured":"Gazioglu O, Kareem BO, Afzal M, Shafeeq S, Kuipers OP, Ulijasz AT, Andrew PW, Yesilkaya H. Glutamate dehydrogenase (GdhA) of Streptococcus pneumoniae is required for high temperature adaptation. Infect Immun. 2021;89(12):e0040021.","journal-title":"Infect Immun"},{"issue":"2","key":"4637_CR63","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","volume":"17","author":"KL Winthrop","year":"2020","unstructured":"Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. Managed care health Plan, 2008\u20132015. Annals Am Thorac Soc. 2020;17(2):178\u201385.","journal-title":"Annals Am Thorac Soc"},{"issue":"6","key":"4637_CR64","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3201\/eid2406.172095","volume":"24","author":"M Santin","year":"2018","unstructured":"Santin M, Barrabeig I, Malchair P, Gonzalez-Luquero L, Benitez MA, Sabria J, Palau-Benavent M, Canete C, Lloret-Queralto JA, Grijota-Camino MD, et al. Pulmonary infections with nontuberculous Mycobacteria, Catalonia, Spain, 1994\u20132014. Emerg Infect Dis. 2018;24(6):1091\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"4637_CR65","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4269\/ajtmh.21-0095","volume":"105","author":"P Suresh","year":"2021","unstructured":"Suresh P, Kumar A, Biswas R, Vijayakumar D, Thulasidharan S, Anjaneyan G, Kunoor A, Biswas L. Epidemiology of nontuberculous mycobacterial infection in tuberculosis suspects. Am J Trop Med Hyg. 2021;105(5):1335\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"4637_CR66","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1055\/s-0038-1660864","volume":"39","author":"SMH Zweijpfenning","year":"2018","unstructured":"Zweijpfenning SMH, Ingen JV, Hoefsloot W. Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: A systematic review. Semin Respir Crit Care Med. 2018;39(3):336\u201342.","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"4637_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41597-025-04504-z","volume":"12","author":"P Lasch","year":"2025","unstructured":"Lasch P, Beyer W, Bosch A, Borriss R, Drevinek M, Dupke S, Ehling-Schulz M, Gao X, Grunow R, Jacob D, et al. A MALDI-ToF mass spectrometry database for identification and classification of highly pathogenic bacteria. Sci Data. 2025;12(1):187.","journal-title":"Sci Data"},{"issue":"4","key":"4637_CR68","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4103\/ijmy.ijmy_93_19","volume":"8","author":"MB Nagmoti","year":"2019","unstructured":"Nagmoti MB, Kulgod SY, Narang R, Mulla RG. Diagnosis and management of postlaparotomy wound infection caused by Mycobacterium fortuitum. Int J Mycobacteriology. 2019;8(4):400\u20132.","journal-title":"Int J Mycobacteriology"},{"issue":"1","key":"4637_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12872-019-1028-0","volume":"19","author":"J Zhu","year":"2019","unstructured":"Zhu J, Yang Q, Pan J, Shi H, Jin B, Chen Q. Cardiac resynchronization therapy-defibrillator pocket infection caused by Mycobacterium fortuitum: a case report and review of the literature. BMC Cardiovasc Disord. 2019;19(1):53.","journal-title":"BMC Cardiovasc Disord"},{"key":"4637_CR70","doi-asserted-by":"publisher","first-page":"791918","DOI":"10.3389\/fmicb.2021.791918","volume":"12","author":"Q Ma","year":"2021","unstructured":"Ma Q, Chen R, Yang E, Yuan Y, Tian Y, Han Y, Wang S, Wang B, Yan W, Zhang Q, et al. Non-tuberculous mycobacterial infection of the musculoskeletal system detected at two tertiary medical centres in Henan, China, 2016\u20132020. Front Microbiol. 2021;12:791918.","journal-title":"Front Microbiol"},{"issue":"1","key":"4637_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41579-023-00958-3","volume":"22","author":"JY Maillard","year":"2024","unstructured":"Maillard JY, Pascoe M. Disinfectants and antiseptics: mechanisms of action and resistance. Nat Rev Microbiol. 2024;22(1):4\u201317.","journal-title":"Nat Rev Microbiol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04637-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04637-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04637-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:49:57Z","timestamp":1770266997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04637-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4637"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04637-6","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the collection of\n                      Mycolicibacterium houstonense\n                      hospital isolates and background clinical data was obtained from the Medical Ethics Committee of Changshu Hospital Affiliated to Soochow University, Changshu NO.1 People\u2019s Hospital, Jiangsu, China, with approval number L2025037. This study was conducted in accordance with Helsinki Declaration. According to the Changshu Hospital Affiliated to Soochow University Medical Ethics Committee, informed consent was deemed unnecessary because the isolate was obtained from residual pus specimens remaining after the completion of clinical microbiological testing of hospitalized patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}